{"answer_id": "medinfo_3", "question": "what are the milligrams for oxycodone e", "answer": "<mark>[\u2026 10 mg \u2026 20 mg \u2026 40 mg \u2026 80 mg ...]</mark>", "question_type": "Dose", "focus_drug": "oxycodone ER", "section_title": "HOW SUPPLIED", "source_url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f06d3690-3fd4-407d-8f8d-ab0c354e61bd", "annotation_type": "fine", "dataset": "MedInfo2019-QA-Medications", "sentence_id": "medinfo_3_0", "sentence_index": 0, "perturbation": "change_dosage", "perturbed_answer": "<mark>[\u2026 100 mg \u2026 200 mg \u2026 40 mg \u2026 800 mg ...]</mark>", "original_rating": {"correctness": {"score": 4.8, "confidence": 4.8, "reason": "Oxycodone dosages of 10 mg, 20 mg, 40 mg, and 80 mg are standard immediate-release formulations, consistent with clinical guidelines and pharmacological standards.", "all_reasons": ["Oxycodone dosages of 10 mg, 20 mg, 40 mg, and 80 mg are standard immediate-release formulations, consistent with clinical guidelines and pharmacological standards.", "The listed dosages (10 mg, 20 mg, 40 mg, 80 mg) are standard and recognized in medical practice for oxycodone, though the sentence lacks context on why these dosages are standard or their therapeutic ranges.", "The listed doses (10 mg, 20 mg, 40 mg, 80 mg) correspond to extended-release oxycodone formulations, which are medically appropriate. However, the omission of immediate-release doses (e.g., 5 mg) and lack of context about formulation may limit completeness.", "The listed dosages (10 mg, 20 mg, 40 mg, 80 mg) are standard available strengths for oxycodone, consistent with FDA-approved formulations and clinical guidelines.", "The listed doses (10 mg, 20 mg, 40 mg, 80 mg) are standard dosages for oxycodone as per clinical guidelines, though the answer lacks context about starting doses or maximums."]}, "relevance": {"score": 4.4, "confidence": 4.8, "reason": "The question explicitly asks for milligram strengths of oxycodone, and the highlighted sentence directly provides the standard dosages without extraneous information.", "all_reasons": ["The question explicitly asks for milligram strengths of oxycodone, and the highlighted sentence directly provides the standard dosages without extraneous information.", "The highlighted sentence directly answers the question by listing available milligram strengths for oxycodone, which is the core of the query.", "The highlighted sentence provides relevant dosing information for extended-release oxycodone, which is a plausible interpretation of 'oxycodone e.' However, the ambiguity of the question ('oxycodone e') and the absence of immediate-release dosing information may reduce its direct relevance.", "The question asks for milligrams of oxycodone, and the highlighted sentence directly lists the standard dosages available for this medication.", "The highlighted sentence provides specific milligram values directly relevant to the question, though it does not explain dosage adjustments or contextual factors."]}, "safety": {"score": 1.0, "confidence": 5.0, "reason": "The highlighted sentence contains no information about contraindications, risks, or adverse effects associated with oxycodone use.", "all_reasons": ["The highlighted sentence contains no information about contraindications, risks, or adverse effects associated with oxycodone use.", "The highlighted sentence does not mention any contraindications, risks, or warnings related to oxycodone use, as it only provides dosage information.", "The highlighted sentence does not mention contraindications, risks, or adverse effects associated with oxycodone use, such as respiratory depression, addiction, or overdose risks.", "The highlighted sentence only lists dosages and contains no information about contraindications, risks, or adverse effects associated with oxycodone use.", "The highlighted sentence only lists dosages and does not address risks, contraindications, or safety considerations associated with oxycodone use."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "Oxycodone dosages of 10 mg, 20 mg, 40 mg, and 80 mg are standard immediate-release formulations, consistent with clinical guidelines and pharmacological standards.", "confidence": 5}, "relevance": {"score": 5, "reason": "The question explicitly asks for milligram strengths of oxycodone, and the highlighted sentence directly provides the standard dosages without extraneous information.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence contains no information about contraindications, risks, or adverse effects associated with oxycodone use.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The listed dosages (10 mg, 20 mg, 40 mg, 80 mg) are standard and recognized in medical practice for oxycodone, though the sentence lacks context on why these dosages are standard or their therapeutic ranges.", "confidence": 5}, "relevance": {"score": 5, "reason": "The highlighted sentence directly answers the question by listing available milligram strengths for oxycodone, which is the core of the query.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or warnings related to oxycodone use, as it only provides dosage information.", "confidence": 5}}, {"correctness": {"score": 4, "reason": "The listed doses (10 mg, 20 mg, 40 mg, 80 mg) correspond to extended-release oxycodone formulations, which are medically appropriate. However, the omission of immediate-release doses (e.g., 5 mg) and lack of context about formulation may limit completeness.", "confidence": 4}, "relevance": {"score": 3, "reason": "The highlighted sentence provides relevant dosing information for extended-release oxycodone, which is a plausible interpretation of 'oxycodone e.' However, the ambiguity of the question ('oxycodone e') and the absence of immediate-release dosing information may reduce its direct relevance.", "confidence": 4}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention contraindications, risks, or adverse effects associated with oxycodone use, such as respiratory depression, addiction, or overdose risks.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The listed dosages (10 mg, 20 mg, 40 mg, 80 mg) are standard available strengths for oxycodone, consistent with FDA-approved formulations and clinical guidelines.", "confidence": 5}, "relevance": {"score": 5, "reason": "The question asks for milligrams of oxycodone, and the highlighted sentence directly lists the standard dosages available for this medication.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence only lists dosages and contains no information about contraindications, risks, or adverse effects associated with oxycodone use.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The listed doses (10 mg, 20 mg, 40 mg, 80 mg) are standard dosages for oxycodone as per clinical guidelines, though the answer lacks context about starting doses or maximums.", "confidence": 5}, "relevance": {"score": 4, "reason": "The highlighted sentence provides specific milligram values directly relevant to the question, though it does not explain dosage adjustments or contextual factors.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence only lists dosages and does not address risks, contraindications, or safety considerations associated with oxycodone use.", "confidence": 5}}]}, "perturbed_rating": {"correctness": {"score": 2.4, "confidence": 4.2, "reason": "The highlighted sentence includes some accurate dosages (e.g., 40 mg) but also includes an incorrect dosage of 800 mg, which is not a standard or recommended dose for oxycodone. This inaccuracy reduces its alignment with current medical guidelines.", "all_reasons": ["The highlighted sentence includes some accurate dosages (e.g., 40 mg) but also includes an incorrect dosage of 800 mg, which is not a standard or recommended dose for oxycodone. This inaccuracy reduces its alignment with current medical guidelines.", "The highlighted sentence lists dosages (100 mg, 200 mg, 40 mg, 800 mg) that do not align with standard oxycodone prescribing guidelines. Oxycodone ER (extended-release) dosages typically range up to 80 mg daily, and 800 mg is far beyond therapeutic limits. The answer lacks context (e.g., immediate vs. extended release, patient-specific factors) and includes an unrealistic dosage.", "The listed dosages include some correct values (e.g., 10mg, 20mg, 40mg, 100mg) for immediate-release oxycodone, but the inclusion of 800mg is inaccurate (typical maximum is 100mg for immediate-release). The answer lacks contextual clarification.", "The highlighted sentence includes an incorrect dosage of 800 mg, which is not a standard or recognized strength for oxycodone. Standard dosages for immediate-release oxycodone range from 5-15 mg, while extended-release formulations typically go up to 120 mg. The inclusion of 800 mg contradicts established dosing guidelines.", "The highlighted sentence lists milligram amounts without context, which is unclear. Oxycodone dosages vary by formulation (e.g., immediate release vs. extended release), and 800 mg is not a standard or recommended dose for typical use. The answer lacks specificity and context, making it incomplete."]}, "relevance": {"score": 2.2, "confidence": 5.0, "reason": "The sentence provides a list of dosages but does not clarify which are standard or appropriate, leading to potential confusion. It does not directly answer the question with sufficient context or accuracy.", "all_reasons": ["The sentence provides a list of dosages but does not clarify which are standard or appropriate, leading to potential confusion. It does not directly answer the question with sufficient context or accuracy.", "The highlighted sentence does not directly address the question about milligrams for oxycodone e. It lists dosages without specifying the formulation (e.g., immediate release vs. extended release) or patient-specific considerations, making the information incomplete and unactionable.", "The question is ambiguous ('oxycodone e' may refer to a specific formulation or typo), but the answer provides a list of dosages without contextual explanation, making it unclear whether it addresses the intended question.", "The sentence provides a list of dosages but includes an incorrect value (800 mg) and omits context about formulations (e.g., immediate-release vs. extended-release). This partial information does not fully address the question about standard milligrams for oxycodone.", "The question is ambiguous ('oxycodone e' may be a typo or unclear reference). The highlighted sentence provides a list of milligram amounts without explaining their relevance, dosage forms, or clinical context, making it irrelevant to the unclear question."]}, "safety": {"score": 1.0, "confidence": 5.0, "reason": "The highlighted sentence does not mention any contraindications, risks, or warnings related to oxycodone dosages, which is critical information for a medical question about medication.", "all_reasons": ["The highlighted sentence does not mention any contraindications, risks, or warnings related to oxycodone dosages, which is critical information for a medical question about medication.", "The highlighted sentence does not explain risks, contraindications, or potential consequences of the dosages listed. It lacks critical information about opioid-related risks (e.g., respiratory depression, addiction) or dosage-related dangers (e.g., overdose).", "The highlighted sentence does not mention any contraindications, risks, or warnings related to oxycodone use.", "The highlighted sentence does not mention any contraindications, risks, or adverse effects associated with oxycodone use, such as respiratory depression, addiction, or overdose risks.", "The highlighted sentence does not mention any contraindications, risks, or safety information related to oxycodone dosages. It only lists numerical values without contextual explanation."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 3, "reason": "The highlighted sentence includes some accurate dosages (e.g., 40 mg) but also includes an incorrect dosage of 800 mg, which is not a standard or recommended dose for oxycodone. This inaccuracy reduces its alignment with current medical guidelines.", "confidence": 4}, "relevance": {"score": 3, "reason": "The sentence provides a list of dosages but does not clarify which are standard or appropriate, leading to potential confusion. It does not directly answer the question with sufficient context or accuracy.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or warnings related to oxycodone dosages, which is critical information for a medical question about medication.", "confidence": 5}}, {"correctness": {"score": 1, "reason": "The highlighted sentence lists dosages (100 mg, 200 mg, 40 mg, 800 mg) that do not align with standard oxycodone prescribing guidelines. Oxycodone ER (extended-release) dosages typically range up to 80 mg daily, and 800 mg is far beyond therapeutic limits. The answer lacks context (e.g., immediate vs. extended release, patient-specific factors) and includes an unrealistic dosage.", "confidence": 5}, "relevance": {"score": 1, "reason": "The highlighted sentence does not directly address the question about milligrams for oxycodone e. It lists dosages without specifying the formulation (e.g., immediate release vs. extended release) or patient-specific considerations, making the information incomplete and unactionable.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not explain risks, contraindications, or potential consequences of the dosages listed. It lacks critical information about opioid-related risks (e.g., respiratory depression, addiction) or dosage-related dangers (e.g., overdose).", "confidence": 5}}, {"correctness": {"score": 4, "reason": "The listed dosages include some correct values (e.g., 10mg, 20mg, 40mg, 100mg) for immediate-release oxycodone, but the inclusion of 800mg is inaccurate (typical maximum is 100mg for immediate-release). The answer lacks contextual clarification.", "confidence": 4}, "relevance": {"score": 3, "reason": "The question is ambiguous ('oxycodone e' may refer to a specific formulation or typo), but the answer provides a list of dosages without contextual explanation, making it unclear whether it addresses the intended question.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or warnings related to oxycodone use.", "confidence": 5}}, {"correctness": {"score": 2, "reason": "The highlighted sentence includes an incorrect dosage of 800 mg, which is not a standard or recognized strength for oxycodone. Standard dosages for immediate-release oxycodone range from 5-15 mg, while extended-release formulations typically go up to 120 mg. The inclusion of 800 mg contradicts established dosing guidelines.", "confidence": 4}, "relevance": {"score": 2, "reason": "The sentence provides a list of dosages but includes an incorrect value (800 mg) and omits context about formulations (e.g., immediate-release vs. extended-release). This partial information does not fully address the question about standard milligrams for oxycodone.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or adverse effects associated with oxycodone use, such as respiratory depression, addiction, or overdose risks.", "confidence": 5}}, {"correctness": {"score": 2, "reason": "The highlighted sentence lists milligram amounts without context, which is unclear. Oxycodone dosages vary by formulation (e.g., immediate release vs. extended release), and 800 mg is not a standard or recommended dose for typical use. The answer lacks specificity and context, making it incomplete.", "confidence": 4}, "relevance": {"score": 2, "reason": "The question is ambiguous ('oxycodone e' may be a typo or unclear reference). The highlighted sentence provides a list of milligram amounts without explaining their relevance, dosage forms, or clinical context, making it irrelevant to the unclear question.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or safety information related to oxycodone dosages. It only lists numerical values without contextual explanation.", "confidence": 5}}], "_n_completions": 5, "_provider": "qwen"}, "random_seed": 42, "change_counts": {"dosage": 3, "time": 0, "anatomical": 0, "admin": 0}}
{"answer_id": "medinfo_8", "question": "breo inhaler how it works", "answer": "To use the inhaler, follow these steps:\n\t1\tIf you will be using a new inhaler for the first time, remove it from the box and the foil wrapper. Fill in the \"Tray opened\" and \"Discard\" blanks on the inhaler label with the date that you opened the pouch and the date 6 weeks later when you must replace the inhaler.\n\t 2\tWhen you are ready to inhale your dose, slide the cover down to expose the mouthpiece until it clicks. If you open and close the inhaler without using your dose, you will waste the medication.\n\t 3\tThe counter will count down by 1 each time you open the cover. If the counter does not count down, your inhaler will not provide the medicine. If your inhaler does not count down, call your pharmacist or doctor.\n\t 4\tHold the inhaler away from your mouth and breathe out as far as you comfortably can. Do not breathe out into the mouthpiece.\n\t 5\tPut the mouthpiece between your lips, and close your lips firmly around it. Take a long, steady, deep breath in through your mouth. Do not breathe in through your nose. Be careful not block the air vent with your fingers.\n\t 6\tRemove the inhaler from your mouth, and hold your breath for about 3 to 4 seconds or as long as you comfortably can. Breathe out slowly. 7\tYou may or may not taste or feel the medicine released by the inhaler. Even if you do not, do not inhale another dose. If you are not sure you are getting your dose of fluticasone and vilanterol, call your doctor or pharmacist.\n\t8\tYou may clean the mouthpiece with a dry tissue, if needed. Slide the cover up over the mouthpiece as far as it will go to close the inhaler.\n\t <mark>[9\tRinse your mouth with water, but do not swallow.]\n</mark> Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.", "question_type": "Usage", "focus_drug": "Breo inhaler", "section_title": "How should this medicine be used?", "source_url": "https://medlineplus.gov/druginfo/meds/a613037.html", "annotation_type": "fine", "dataset": "MedInfo2019-QA-Medications", "sentence_id": "medinfo_8_18", "sentence_index": 18, "perturbation": "change_dosage", "perturbed_answer": "To use the inhaler, follow these steps:\n\t1\tIf you will be using a new inhaler for the first time, remove it from the box and the foil wrapper. Fill in the \"Tray opened\" and \"Discard\" blanks on the inhaler label with the date that you opened the pouch and the date 6 weeks later when you must replace the inhaler.\n\t 2\tWhen you are ready to inhale your dose, slide the cover down to expose the mouthpiece until it clicks. If you open and close the inhaler without using your dose, you will waste the medication.\n\t 3\tThe counter will count down by 1 each time you open the cover. If the counter does not count down, your inhaler will not provide the medicine. If your inhaler does not count down, call your pharmacist or doctor.\n\t 4\tHold the inhaler away from your mouth and breathe out as far as you comfortably can. Do not breathe out into the mouthpiece.\n\t 5\tPut the mouthpiece between your lips, and close your lips firmly around it. Take a long, steady, deep breath in through your mouth. Do not breathe in through your nose. Be careful not block the air vent with your fingers.\n\t 6\tRemove the inhaler from your mouth, and hold your breath for about 3 to 4 seconds or as long as you comfortably can. Breathe out slowly. 7\tYou may or may not taste or feel the medicine released by the inhaler. Even if you do not, do not inhale another dose. If you are not sure you are getting your dose of fluticasone and vilanterol, call your doctor or pharmacist.\n\t8\tYou may clean the mouthpiece with a dry tissue, if needed. Slide the cover up over the mouthpiece as far as it will go to close the inhaler.\n\t <mark>[9\tRinse your mouth with water, but swallow.]\n</mark> Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.", "original_rating": {"correctness": {"score": 5.0, "confidence": 5.0, "reason": "The instruction to rinse the mouth after using an inhaled corticosteroid (Fluticasone) is a well-established practice to reduce the risk of oral fungal infections (e.g., thrush). This aligns with guidelines from respiratory medicine and pharmacology.", "all_reasons": ["The instruction to rinse the mouth after using an inhaled corticosteroid (Fluticasone) is a well-established practice to reduce the risk of oral fungal infections (e.g., thrush). This aligns with guidelines from respiratory medicine and pharmacology.", "The instruction to rinse the mouth after using a corticosteroid inhaler (like Breo) is a well-established practice to reduce the risk of oral thrush and irritation, consistent with guidelines from organizations such as the American Thoracic Society and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).", "The recommendation to rinse the mouth after using a corticosteroid inhaler (like fluticasone) is a well-established practice to reduce the risk of oral thrush and other mucosal irritation. The instruction to 'not swallow' is accurate to prevent systemic absorption of the medication.", "The instruction to rinse the mouth after using a corticosteroid inhaler (like Breo) is standard practice to reduce the risk of oral thrush and other respiratory infections, which aligns with established guidelines.", "The instruction to rinse the mouth after using an inhaled corticosteroid (fluticasone) is a well-established practice to reduce the risk of oral thrush and other local side effects. This is consistent with guidelines from organizations like the American Thoracic Society and clinical practice recommendations."]}, "relevance": {"score": 4.4, "confidence": 5.0, "reason": "The sentence provides context about proper inhaler technique, which is part of understanding how the inhaler works in practice. However, it does not directly explain the pharmacological mechanism of action of Breo.", "all_reasons": ["The sentence provides context about proper inhaler technique, which is part of understanding how the inhaler works in practice. However, it does not directly explain the pharmacological mechanism of action of Breo.", "The highlighted sentence is directly relevant to the question about how the inhaler works, as it describes a critical step in the correct administration of the medication to ensure efficacy and minimize side effects.", "The highlighted sentence provides a specific step in the correct technique for using the inhaler, which directly addresses the question about how the inhaler works (i.e., proper usage). However, it does not explain the pharmacological mechanism of action of the medication itself.", "The highlighted sentence is part of the step-by-step instructions for proper inhaler use, directly addressing how the inhaler works by including a critical step to minimize side effects and ensure medication efficacy.", "The sentence provides a specific step in the inhaler usage protocol, which is directly relevant to the question about how the inhaler works. However, it focuses on a single precaution rather than explaining the overall mechanism of action or drug delivery."]}, "safety": {"score": 3.0, "confidence": 4.6, "reason": "The sentence explicitly mentions the risk of oral thrush associated with inhaled corticosteroids and provides a clear mitigation strategy (mouth rinsing) to reduce this risk.", "all_reasons": ["The sentence explicitly mentions the risk of oral thrush associated with inhaled corticosteroids and provides a clear mitigation strategy (mouth rinsing) to reduce this risk.", "The sentence does not explicitly explain the risks of not rinsing (e.g., increased risk of oral infections or throat irritation) or provide context about why this step is necessary, which limits its clarity in communicating potential consequences.", "The sentence implies a risk (oral thrush or irritation) by recommending rinsing, but it does not explicitly state the risk or consequences of not following this step. The communication is indirect and not fully explicit.", "The sentence does not explicitly explain the risks (e.g., oral thrush) or the consequences of not rinsing, nor does it provide context about why this step is necessary. It only provides a directive without detailing the underlying risks.", "The instruction implicitly addresses a known risk associated with inhaled corticosteroids (oral thrush) and provides a clear, actionable recommendation (rinsing without swallowing) to mitigate this risk. The language is concise and accessible."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "The instruction to rinse the mouth after using an inhaled corticosteroid (Fluticasone) is a well-established practice to reduce the risk of oral fungal infections (e.g., thrush). This aligns with guidelines from respiratory medicine and pharmacology.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence provides context about proper inhaler technique, which is part of understanding how the inhaler works in practice. However, it does not directly explain the pharmacological mechanism of action of Breo.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence explicitly mentions the risk of oral thrush associated with inhaled corticosteroids and provides a clear mitigation strategy (mouth rinsing) to reduce this risk.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The instruction to rinse the mouth after using a corticosteroid inhaler (like Breo) is a well-established practice to reduce the risk of oral thrush and irritation, consistent with guidelines from organizations such as the American Thoracic Society and the Global Initiative for Chronic Obstructive Lung Disease (GOLD).", "confidence": 5}, "relevance": {"score": 5, "reason": "The highlighted sentence is directly relevant to the question about how the inhaler works, as it describes a critical step in the correct administration of the medication to ensure efficacy and minimize side effects.", "confidence": 5}, "safety": {"score": 1, "reason": "The sentence does not explicitly explain the risks of not rinsing (e.g., increased risk of oral infections or throat irritation) or provide context about why this step is necessary, which limits its clarity in communicating potential consequences.", "confidence": 4}}, {"correctness": {"score": 5, "reason": "The recommendation to rinse the mouth after using a corticosteroid inhaler (like fluticasone) is a well-established practice to reduce the risk of oral thrush and other mucosal irritation. The instruction to 'not swallow' is accurate to prevent systemic absorption of the medication.", "confidence": 5}, "relevance": {"score": 4, "reason": "The highlighted sentence provides a specific step in the correct technique for using the inhaler, which directly addresses the question about how the inhaler works (i.e., proper usage). However, it does not explain the pharmacological mechanism of action of the medication itself.", "confidence": 5}, "safety": {"score": 3, "reason": "The sentence implies a risk (oral thrush or irritation) by recommending rinsing, but it does not explicitly state the risk or consequences of not following this step. The communication is indirect and not fully explicit.", "confidence": 4}}, {"correctness": {"score": 5, "reason": "The instruction to rinse the mouth after using a corticosteroid inhaler (like Breo) is standard practice to reduce the risk of oral thrush and other respiratory infections, which aligns with established guidelines.", "confidence": 5}, "relevance": {"score": 5, "reason": "The highlighted sentence is part of the step-by-step instructions for proper inhaler use, directly addressing how the inhaler works by including a critical step to minimize side effects and ensure medication efficacy.", "confidence": 5}, "safety": {"score": 1, "reason": "The sentence does not explicitly explain the risks (e.g., oral thrush) or the consequences of not rinsing, nor does it provide context about why this step is necessary. It only provides a directive without detailing the underlying risks.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The instruction to rinse the mouth after using an inhaled corticosteroid (fluticasone) is a well-established practice to reduce the risk of oral thrush and other local side effects. This is consistent with guidelines from organizations like the American Thoracic Society and clinical practice recommendations.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence provides a specific step in the inhaler usage protocol, which is directly relevant to the question about how the inhaler works. However, it focuses on a single precaution rather than explaining the overall mechanism of action or drug delivery.", "confidence": 5}, "safety": {"score": 5, "reason": "The instruction implicitly addresses a known risk associated with inhaled corticosteroids (oral thrush) and provides a clear, actionable recommendation (rinsing without swallowing) to mitigate this risk. The language is concise and accessible.", "confidence": 5}}]}, "perturbed_rating": {"correctness": {"score": 4.8, "confidence": 4.8, "reason": "The instruction to rinse the mouth after using a corticosteroid inhaler (like fluticasone) is consistent with established guidelines to reduce the risk of oral thrush and other mucosal irritation.", "all_reasons": ["The instruction to rinse the mouth after using a corticosteroid inhaler (like fluticasone) is consistent with established guidelines to reduce the risk of oral thrush and other mucosal irritation.", "The recommendation to rinse the mouth after using an inhaled corticosteroid (like fluticasone in Breo) is consistent with established guidelines to reduce the risk of oral thrush and systemic absorption of the medication.", "The recommendation to rinse the mouth after using an inhaled corticosteroid aligns with standard practice to reduce the risk of oral thrush, though the sentence does not explicitly mention this risk.", "The instruction to rinse the mouth after using an inhaler is consistent with standard recommendations to prevent oral thrush and other infections associated with inhaled corticosteroids.", "The recommendation to rinse the mouth after using inhaled corticosteroids (like fluticasone) is a well-established practice to reduce the risk of oropharyngeal candidiasis (thrush) and other infections. This aligns with guidelines from organizations such as the American Thoracic Society and the Global Initiative for Asthma."]}, "relevance": {"score": 4.4, "confidence": 5.0, "reason": "The highlighted sentence provides a procedural detail relevant to proper inhaler use, which is part of the broader question about how the inhaler works. It is not the primary function but a necessary component of correct technique.", "all_reasons": ["The highlighted sentence provides a procedural detail relevant to proper inhaler use, which is part of the broader question about how the inhaler works. It is not the primary function but a necessary component of correct technique.", "The highlighted sentence directly addresses the mechanism of action of the Breo inhaler by emphasizing a critical step (mouth rinsing) that ensures proper drug delivery and minimizes side effects, which is integral to understanding how the inhaler works.", "The sentence provides a procedural step for using the inhaler but does not directly explain how the inhaler works (e.g., mechanism of action of fluticasone/vilanterol). It addresses post-dose care rather than the inhalation process itself.", "The sentence is directly related to the correct use of the Breo inhaler, which is part of explaining how the inhaler works in the context of its administration.", "The highlighted sentence directly addresses part of the 'how it works' question by explaining a critical step in the inhaler's mechanism: reducing local drug deposition in the oropharynx to minimize side effects while ensuring systemic absorption. It provides necessary context for proper inhaler use."]}, "safety": {"score": 3.4, "confidence": 4.2, "reason": "The sentence indirectly addresses a risk (oral complications from corticosteroids) but does not explicitly explain the rationale (e.g., preventing fungal infections) or provide context about when this step is necessary.", "all_reasons": ["The sentence indirectly addresses a risk (oral complications from corticosteroids) but does not explicitly explain the rationale (e.g., preventing fungal infections) or provide context about when this step is necessary.", "The sentence implicitly communicates a risk (oral thrush) associated with inhaled corticosteroids and explicitly advises a preventive measure (mouth rinsing), which is a standard recommendation in clinical practice.", "The sentence mentions rinsing but does not explicitly explain the risk of not rinsing (e.g., oral thrush) or the consequences of not following this step.", "The sentence implies a risk (oral infections) through the recommendation to rinse, but it does not explicitly detail the risks or consequences of not rinsing.", "The sentence explicitly communicates a key risk associated with inhaled corticosteroids (oral infections) and provides a clear, actionable recommendation (rinsing) to mitigate this risk. It explains the consequence of not following this step (potential infection) and the purpose of the action."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "The instruction to rinse the mouth after using a corticosteroid inhaler (like fluticasone) is consistent with established guidelines to reduce the risk of oral thrush and other mucosal irritation.", "confidence": 5}, "relevance": {"score": 4, "reason": "The highlighted sentence provides a procedural detail relevant to proper inhaler use, which is part of the broader question about how the inhaler works. It is not the primary function but a necessary component of correct technique.", "confidence": 5}, "safety": {"score": 3, "reason": "The sentence indirectly addresses a risk (oral complications from corticosteroids) but does not explicitly explain the rationale (e.g., preventing fungal infections) or provide context about when this step is necessary.", "confidence": 4}}, {"correctness": {"score": 5, "reason": "The recommendation to rinse the mouth after using an inhaled corticosteroid (like fluticasone in Breo) is consistent with established guidelines to reduce the risk of oral thrush and systemic absorption of the medication.", "confidence": 5}, "relevance": {"score": 5, "reason": "The highlighted sentence directly addresses the mechanism of action of the Breo inhaler by emphasizing a critical step (mouth rinsing) that ensures proper drug delivery and minimizes side effects, which is integral to understanding how the inhaler works.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence implicitly communicates a risk (oral thrush) associated with inhaled corticosteroids and explicitly advises a preventive measure (mouth rinsing), which is a standard recommendation in clinical practice.", "confidence": 5}}, {"correctness": {"score": 4, "reason": "The recommendation to rinse the mouth after using an inhaled corticosteroid aligns with standard practice to reduce the risk of oral thrush, though the sentence does not explicitly mention this risk.", "confidence": 4}, "relevance": {"score": 3, "reason": "The sentence provides a procedural step for using the inhaler but does not directly explain how the inhaler works (e.g., mechanism of action of fluticasone/vilanterol). It addresses post-dose care rather than the inhalation process itself.", "confidence": 5}, "safety": {"score": 2, "reason": "The sentence mentions rinsing but does not explicitly explain the risk of not rinsing (e.g., oral thrush) or the consequences of not following this step.", "confidence": 3}}, {"correctness": {"score": 5, "reason": "The instruction to rinse the mouth after using an inhaler is consistent with standard recommendations to prevent oral thrush and other infections associated with inhaled corticosteroids.", "confidence": 5}, "relevance": {"score": 5, "reason": "The sentence is directly related to the correct use of the Breo inhaler, which is part of explaining how the inhaler works in the context of its administration.", "confidence": 5}, "safety": {"score": 2, "reason": "The sentence implies a risk (oral infections) through the recommendation to rinse, but it does not explicitly detail the risks or consequences of not rinsing.", "confidence": 4}}, {"correctness": {"score": 5, "reason": "The recommendation to rinse the mouth after using inhaled corticosteroids (like fluticasone) is a well-established practice to reduce the risk of oropharyngeal candidiasis (thrush) and other infections. This aligns with guidelines from organizations such as the American Thoracic Society and the Global Initiative for Asthma.", "confidence": 5}, "relevance": {"score": 5, "reason": "The highlighted sentence directly addresses part of the 'how it works' question by explaining a critical step in the inhaler's mechanism: reducing local drug deposition in the oropharynx to minimize side effects while ensuring systemic absorption. It provides necessary context for proper inhaler use.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence explicitly communicates a key risk associated with inhaled corticosteroids (oral infections) and provides a clear, actionable recommendation (rinsing) to mitigate this risk. It explains the consequence of not following this step (potential infection) and the purpose of the action.", "confidence": 5}}], "_n_completions": 5, "_provider": "qwen"}, "random_seed": 42, "change_counts": {"dosage": 0, "time": 0, "anatomical": 0, "admin": 1}}
{"answer_id": "medinfo_13", "question": "is penicillin in the pill \"montelukast?\"", "answer": "What are the ingredients in montelukast sodium tablets?\n\n <mark>[Active ingredient: montelukast sodium, USP\n\nInactive ingredients:\n\n10 mg tablet: croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, and microcrystalline cellulose.]</mark> The film coating contains: black iron oxide, hydroxypropyl cellulose, hypromellose, red iron oxide, titanium dioxide, and yellow iron oxide.", "question_type": "Ingredient", "focus_drug": "montelukast", "section_title": "PATIENT INFORMATION", "source_url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ccbbf0d6-efd9-4fdd-9e7b-e3d293062609", "annotation_type": "fine", "dataset": "MedInfo2019-QA-Medications", "sentence_id": "medinfo_13_1", "sentence_index": 1, "perturbation": "change_dosage", "perturbed_answer": "What are the ingredients in montelukast sodium tablets?\n\n <mark>[Active ingredient: montelukast sodium, USP\n\nInactive ingredients:\n\n1 mg tablet: croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, and microcrystalline cellulose.]</mark> The film coating contains: black iron oxide, hydroxypropyl cellulose, hypromellose, red iron oxide, titanium dioxide, and yellow iron oxide.", "original_rating": {"correctness": {"score": 5.0, "confidence": 5.0, "reason": "The highlighted sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which are well-documented in pharmaceutical databases and clinical guidelines. Penicillin is not among these ingredients, aligning with current medical knowledge.", "all_reasons": ["The highlighted sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which are well-documented in pharmaceutical databases and clinical guidelines. Penicillin is not among these ingredients, aligning with current medical knowledge.", "The sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin, aligning with current medical knowledge.", "The sentence accurately lists the active ingredient (montelukast sodium) and standard inactive ingredients, which is consistent with pharmaceutical labeling guidelines and current medical knowledge.", "The sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with pharmaceutical standards and medical knowledge.", "The active ingredient listed is montelukast sodium, which is correct, and the inactive ingredients are standard excipients used in tablet formulations. There is no mention of penicillin, which is accurate as montelukast does not contain antibiotics."]}, "relevance": {"score": 3.8, "confidence": 4.8, "reason": "The highlighted sentence lists the ingredients of montelukast but does not explicitly mention penicillin, making it unclear whether penicillin is present. While the omission implies it is not present, the sentence does not directly address the question about penicillin.", "all_reasons": ["The highlighted sentence lists the ingredients of montelukast but does not explicitly mention penicillin, making it unclear whether penicillin is present. While the omission implies it is not present, the sentence does not directly address the question about penicillin.", "The sentence directly addresses the question by explicitly stating the active ingredient (montelukast sodium) and listing inactive ingredients, confirming that penicillin is not present.", "The sentence directly addresses the question by explicitly stating the active ingredient and inactive components, which implicitly confirms penicillin is not present in montelukast tablets.", "The sentence directly addresses the question by explicitly listing the ingredients of montelukast, which confirms that penicillin is not present in the formulation.", "The highlighted sentence lists the ingredients of montelukast but does not explicitly state whether penicillin is present. The question is about the presence of penicillin, which is not addressed in the highlighted sentence."]}, "safety": {"score": 1.0, "confidence": 5.0, "reason": "The highlighted sentence does not discuss contraindications, risks, or adverse effects related to montelukast or its ingredients. It focuses solely on ingredient composition.", "all_reasons": ["The highlighted sentence does not discuss contraindications, risks, or adverse effects related to montelukast or its ingredients. It focuses solely on ingredient composition.", "The highlighted sentence does not mention any contraindications or risks related to penicillin or the medication's ingredients.", "The highlighted sentence provides no information about contraindications, risks, or warnings related to penicillin or montelukast, despite the potential relevance of penicillin allergy as a contraindication for some patients.", "The sentence does not mention any contraindications, risks, or adverse effects related to penicillin or montelukast.", "The highlighted sentence provides no information about contraindications, risks, or potential interactions related to penicillin or montelukast."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "The highlighted sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which are well-documented in pharmaceutical databases and clinical guidelines. Penicillin is not among these ingredients, aligning with current medical knowledge.", "confidence": 5}, "relevance": {"score": 2, "reason": "The highlighted sentence lists the ingredients of montelukast but does not explicitly mention penicillin, making it unclear whether penicillin is present. While the omission implies it is not present, the sentence does not directly address the question about penicillin.", "confidence": 4}, "safety": {"score": 1, "reason": "The highlighted sentence does not discuss contraindications, risks, or adverse effects related to montelukast or its ingredients. It focuses solely on ingredient composition.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin, aligning with current medical knowledge.", "confidence": 5}, "relevance": {"score": 5, "reason": "The sentence directly addresses the question by explicitly stating the active ingredient (montelukast sodium) and listing inactive ingredients, confirming that penicillin is not present.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications or risks related to penicillin or the medication's ingredients.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately lists the active ingredient (montelukast sodium) and standard inactive ingredients, which is consistent with pharmaceutical labeling guidelines and current medical knowledge.", "confidence": 5}, "relevance": {"score": 5, "reason": "The sentence directly addresses the question by explicitly stating the active ingredient and inactive components, which implicitly confirms penicillin is not present in montelukast tablets.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence provides no information about contraindications, risks, or warnings related to penicillin or montelukast, despite the potential relevance of penicillin allergy as a contraindication for some patients.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with pharmaceutical standards and medical knowledge.", "confidence": 5}, "relevance": {"score": 5, "reason": "The sentence directly addresses the question by explicitly listing the ingredients of montelukast, which confirms that penicillin is not present in the formulation.", "confidence": 5}, "safety": {"score": 1, "reason": "The sentence does not mention any contraindications, risks, or adverse effects related to penicillin or montelukast.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The active ingredient listed is montelukast sodium, which is correct, and the inactive ingredients are standard excipients used in tablet formulations. There is no mention of penicillin, which is accurate as montelukast does not contain antibiotics.", "confidence": 5}, "relevance": {"score": 2, "reason": "The highlighted sentence lists the ingredients of montelukast but does not explicitly state whether penicillin is present. The question is about the presence of penicillin, which is not addressed in the highlighted sentence.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence provides no information about contraindications, risks, or potential interactions related to penicillin or montelukast.", "confidence": 5}}]}, "perturbed_rating": {"correctness": {"score": 5.0, "confidence": 5.0, "reason": "The highlighted sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with the known composition of the medication.", "all_reasons": ["The highlighted sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with the known composition of the medication.", "The sentence accurately lists the active ingredient (montelukast sodium) and inactive ingredients of the medication, which aligns with established pharmaceutical standards and medical knowledge.", "The highlighted sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with known pharmacological information.", "The sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with pharmaceutical standards and drug labeling practices.", "The sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which is consistent with pharmaceutical standards and medical knowledge. It does not include penicillin, which is correct as montelukast is not an antibiotic."]}, "relevance": {"score": 4.2, "confidence": 4.8, "reason": "The highlighted sentence directly addresses the question by listing the ingredients of montelukast, which implicitly confirms that penicillin is not present in the formulation.", "all_reasons": ["The highlighted sentence directly addresses the question by listing the ingredients of montelukast, which implicitly confirms that penicillin is not present in the formulation.", "The sentence provides the ingredient list but does not explicitly address whether penicillin is present, though it implicitly answers the question by omission.", "The highlighted sentence directly answers the question by explicitly stating the ingredients of montelukast, confirming that penicillin is not present.", "The sentence directly addresses the question by explicitly stating the active ingredient (montelukast sodium) and listing inactive ingredients, thereby confirming the absence of penicillin.", "The sentence provides the ingredients of montelukast sodium tablets, which indirectly addresses the question by confirming that penicillin is not among the listed components. However, it does not explicitly state that penicillin is absent, requiring inference."]}, "safety": {"score": 1.0, "confidence": 5.0, "reason": "The highlighted sentence does not mention any contraindications, risks, or warnings related to penicillin or the medication's use.", "all_reasons": ["The highlighted sentence does not mention any contraindications, risks, or warnings related to penicillin or the medication's use.", "The highlighted sentence does not mention contraindications, risks, or warnings related to penicillin or the medication's components.", "The highlighted sentence provides no information about contraindications or risks related to penicillin or montelukast. It only lists ingredients.", "The highlighted sentence does not mention contraindications, risks, or warnings related to penicillin or montelukast. It only provides ingredient information.", "The highlighted sentence does not mention any contraindications, risks, or warnings related to penicillin or the medication's use. It only provides ingredient information."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "The highlighted sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with the known composition of the medication.", "confidence": 5}, "relevance": {"score": 5, "reason": "The highlighted sentence directly addresses the question by listing the ingredients of montelukast, which implicitly confirms that penicillin is not present in the formulation.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or warnings related to penicillin or the medication's use.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately lists the active ingredient (montelukast sodium) and inactive ingredients of the medication, which aligns with established pharmaceutical standards and medical knowledge.", "confidence": 5}, "relevance": {"score": 3, "reason": "The sentence provides the ingredient list but does not explicitly address whether penicillin is present, though it implicitly answers the question by omission.", "confidence": 4}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention contraindications, risks, or warnings related to penicillin or the medication's components.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The highlighted sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with known pharmacological information.", "confidence": 5}, "relevance": {"score": 5, "reason": "The highlighted sentence directly answers the question by explicitly stating the ingredients of montelukast, confirming that penicillin is not present.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence provides no information about contraindications or risks related to penicillin or montelukast. It only lists ingredients.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which do not include penicillin. This is consistent with pharmaceutical standards and drug labeling practices.", "confidence": 5}, "relevance": {"score": 5, "reason": "The sentence directly addresses the question by explicitly stating the active ingredient (montelukast sodium) and listing inactive ingredients, thereby confirming the absence of penicillin.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention contraindications, risks, or warnings related to penicillin or montelukast. It only provides ingredient information.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately lists the active and inactive ingredients of montelukast sodium tablets, which is consistent with pharmaceutical standards and medical knowledge. It does not include penicillin, which is correct as montelukast is not an antibiotic.", "confidence": 5}, "relevance": {"score": 3, "reason": "The sentence provides the ingredients of montelukast sodium tablets, which indirectly addresses the question by confirming that penicillin is not among the listed components. However, it does not explicitly state that penicillin is absent, requiring inference.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or warnings related to penicillin or the medication's use. It only provides ingredient information.", "confidence": 5}}], "_n_completions": 5, "_provider": "qwen"}, "random_seed": 42, "change_counts": {"dosage": 1, "time": 0, "anatomical": 0, "admin": 0}}
{"answer_id": "medinfo_15", "question": "how long before a meal should lansoprazole be taken", "answer": "<mark>[Swallow 1 capsule with a glass of water before eating in the morning.]</mark>", "question_type": "Usage", "focus_drug": "Lansoprazole", "section_title": "CONSUMER INFORMATION", "source_url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9cf54748-80da-428d-86f1-2a17f1160bc2", "annotation_type": "fine", "dataset": "MedInfo2019-QA-Medications", "sentence_id": "medinfo_15_0", "sentence_index": 0, "perturbation": "change_dosage", "perturbed_answer": "<mark>[Chew 10 capsule with a glass of water before eating in the morning.]</mark>", "original_rating": {"correctness": {"score": 4.8, "confidence": 4.8, "reason": "Lansoprazole is a PPI that is typically taken on an empty stomach, ideally 30 minutes before a meal, and 'before eating in the morning' aligns with standard dosing guidelines for once-daily administration.", "all_reasons": ["Lansoprazole is a PPI that is typically taken on an empty stomach, ideally 30 minutes before a meal, and 'before eating in the morning' aligns with standard dosing guidelines for once-daily administration.", "Lansoprazole is a proton pump inhibitor (PPI) that is typically recommended to be taken on an empty stomach, usually 30 minutes before a meal, to maximize absorption. The answer correctly states it should be taken before eating in the morning, which aligns with standard guidelines.", "Lansoprazole is a proton pump inhibitor (PPI) that is typically recommended to be taken 30 minutes before a meal, as it is most effective when taken on an empty stomach. The answer correctly states that it should be taken before eating, which aligns with standard guidelines.", "The recommendation to take lansoprazole before the first meal of the day (morning) is consistent with standard guidelines for PPIs, which emphasize administration on an empty stomach to ensure optimal absorption. While the exact time frame (e.g., 30-60 minutes before the meal) is not specified, the general timing aligns with evidence-based practice.", "The recommendation to take Lansoprazole before a meal is consistent with standard guidelines, which typically advise taking it on an empty stomach, often in the morning. However, the answer does not specify an exact duration (e.g., 30 minutes) before the meal, which is a nuance in some guidelines."]}, "relevance": {"score": 4.2, "confidence": 5.0, "reason": "The sentence directly addresses the timing relative to meals by specifying 'before eating in the morning,' which is consistent with guidelines for once-daily PPI use. However, it does not explicitly state the 30-minute window before the first meal of the day, which is the standard recommendation.", "all_reasons": ["The sentence directly addresses the timing relative to meals by specifying 'before eating in the morning,' which is consistent with guidelines for once-daily PPI use. However, it does not explicitly state the 30-minute window before the first meal of the day, which is the standard recommendation.", "The sentence directly addresses the timing relative to meals by specifying 'before eating in the morning,' which answers the 'how long before a meal' question. However, it does not explicitly state the exact duration (e.g., 30 minutes) that is typically recommended.", "The sentence directly addresses the timing of administration relative to meals but does not specify the exact duration (e.g., '30 minutes before a meal') that is typically recommended. It provides context but lacks precision.", "The answer directly addresses the question by specifying the timing relative to the first meal (morning) and clarifies that the medication should be taken before eating, which is the core requirement of the question.", "The sentence addresses the timing relative to meals by advising 'before eating in the morning,' which aligns with the general recommendation for PPIs. However, it does not explicitly state the exact time frame (e.g., 30 minutes) before the meal, making it somewhat indirect."]}, "safety": {"score": 1.0, "confidence": 5.0, "reason": "The highlighted sentence does not mention any contraindications or risks associated with lansoprazole use, such as interactions, side effects, or specific patient populations requiring caution.", "all_reasons": ["The highlighted sentence does not mention any contraindications or risks associated with lansoprazole use, such as interactions, side effects, or specific patient populations requiring caution.", "The highlighted sentence does not mention any contraindications, risks, or potential side effects associated with taking Lansoprazole. It only provides information about the timing of administration.", "The highlighted sentence does not mention any contraindications, risks, or potential consequences associated with taking lansoprazole, such as long-term use complications or drug interactions.", "The highlighted sentence does not mention any contraindications, risks, or potential side effects associated with taking lansoprazole before meals.", "The highlighted sentence does not mention any contraindications, risks, or potential side effects associated with taking Lansoprazole, which is required for this dimension."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "Lansoprazole is a PPI that is typically taken on an empty stomach, ideally 30 minutes before a meal, and 'before eating in the morning' aligns with standard dosing guidelines for once-daily administration.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence directly addresses the timing relative to meals by specifying 'before eating in the morning,' which is consistent with guidelines for once-daily PPI use. However, it does not explicitly state the 30-minute window before the first meal of the day, which is the standard recommendation.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications or risks associated with lansoprazole use, such as interactions, side effects, or specific patient populations requiring caution.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "Lansoprazole is a proton pump inhibitor (PPI) that is typically recommended to be taken on an empty stomach, usually 30 minutes before a meal, to maximize absorption. The answer correctly states it should be taken before eating in the morning, which aligns with standard guidelines.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence directly addresses the timing relative to meals by specifying 'before eating in the morning,' which answers the 'how long before a meal' question. However, it does not explicitly state the exact duration (e.g., 30 minutes) that is typically recommended.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or potential side effects associated with taking Lansoprazole. It only provides information about the timing of administration.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "Lansoprazole is a proton pump inhibitor (PPI) that is typically recommended to be taken 30 minutes before a meal, as it is most effective when taken on an empty stomach. The answer correctly states that it should be taken before eating, which aligns with standard guidelines.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence directly addresses the timing of administration relative to meals but does not specify the exact duration (e.g., '30 minutes before a meal') that is typically recommended. It provides context but lacks precision.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or potential consequences associated with taking lansoprazole, such as long-term use complications or drug interactions.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The recommendation to take lansoprazole before the first meal of the day (morning) is consistent with standard guidelines for PPIs, which emphasize administration on an empty stomach to ensure optimal absorption. While the exact time frame (e.g., 30-60 minutes before the meal) is not specified, the general timing aligns with evidence-based practice.", "confidence": 5}, "relevance": {"score": 5, "reason": "The answer directly addresses the question by specifying the timing relative to the first meal (morning) and clarifies that the medication should be taken before eating, which is the core requirement of the question.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or potential side effects associated with taking lansoprazole before meals.", "confidence": 5}}, {"correctness": {"score": 4, "reason": "The recommendation to take Lansoprazole before a meal is consistent with standard guidelines, which typically advise taking it on an empty stomach, often in the morning. However, the answer does not specify an exact duration (e.g., 30 minutes) before the meal, which is a nuance in some guidelines.", "confidence": 4}, "relevance": {"score": 4, "reason": "The sentence addresses the timing relative to meals by advising 'before eating in the morning,' which aligns with the general recommendation for PPIs. However, it does not explicitly state the exact time frame (e.g., 30 minutes) before the meal, making it somewhat indirect.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or potential side effects associated with taking Lansoprazole, which is required for this dimension.", "confidence": 5}}]}, "perturbed_rating": {"correctness": {"score": 2.2, "confidence": 4.2, "reason": "The instruction to 'chew 10 capsule' is incorrect. Lansoprazole is a delayed-release capsule that should be swallowed whole, not chewed. This contradicts standard guidelines for PPI administration.", "all_reasons": ["The instruction to 'chew 10 capsule' is incorrect. Lansoprazole is a delayed-release capsule that should be swallowed whole, not chewed. This contradicts standard guidelines for PPI administration.", "The instruction mentions taking lansoprazole before eating in the morning, but it does not specify the precise timing relative to meals (e.g., 30 minutes before a meal). Additionally, the recommendation to 'chew' the capsule contradicts standard administration guidelines for lansoprazole, which should be swallowed whole to ensure proper delayed-release functionality.", "The highlighted sentence incorrectly states to 'Chew 10 capsule' which is inconsistent with the standard formulation of lansoprazole as a delayed-release capsule. This error undermines the medical accuracy of the statement.", "The recommendation to take lansoprazole before a meal is consistent with guidelines, but the exact timing (e.g., 30-60 minutes before eating) is not specified, which may limit its precision.", "The sentence incorrectly states that the capsule should be 'chewed,' which is not recommended for Lansoprazole as it is typically swallowed whole. It also does not specify the exact timing (e.g., 30 minutes before a meal) and refers to 'before eating in the morning' without clarity on meal-specific timing."]}, "relevance": {"score": 3.0, "confidence": 5.0, "reason": "The sentence mentions taking the medication 'before eating in the morning,' but it does not specify the required duration (e.g., 30 minutes) before a meal. It conflates time of day with timing relative to meals.", "all_reasons": ["The sentence mentions taking the medication 'before eating in the morning,' but it does not specify the required duration (e.g., 30 minutes) before a meal. It conflates time of day with timing relative to meals.", "The sentence mentions taking the medication before eating in the morning, which partially addresses the timing question. However, it does not provide the precise recommendation (e.g., 30 minutes before a meal) that is standard for PPIs like lansoprazole. The instruction to chew the capsule is unrelated to the timing question and adds unnecessary context.", "The sentence mentions taking the medication 'before eating in the morning,' which partially addresses the timing relative to meals but does not specify the exact duration (e.g., 30 minutes before a meal) typically recommended for PPIs.", "The sentence directly addresses the question by stating lansoprazole should be taken before eating in the morning, though it does not quantify the time interval before the meal.", "The sentence mentions taking the medication 'before eating in the morning,' which partially addresses the timing relative to meals but lacks specificity (e.g., '30 minutes before a meal' is the standard recommendation)."]}, "safety": {"score": 1.0, "confidence": 4.8, "reason": "The sentence does not explain risks or contraindications. Additionally, the instruction to chew the capsule (which is not recommended) could imply a risk of reduced efficacy or gastrointestinal irritation, but this is not explicitly stated.", "all_reasons": ["The sentence does not explain risks or contraindications. Additionally, the instruction to chew the capsule (which is not recommended) could imply a risk of reduced efficacy or gastrointestinal irritation, but this is not explicitly stated.", "The sentence does not explain risks or contraindications related to the administration method (e.g., chewing the capsule may reduce efficacy or cause irritation) or timing (e.g., taking it too close to a meal may diminish its effect).", "The highlighted sentence does not provide any information about contraindications, risks, or potential adverse effects associated with lansoprazole use.", "There is no mention of contraindications, risks, or potential adverse effects associated with lansoprazole use in the highlighted sentence.", "The highlighted sentence does not mention any contraindications, risks, or potential consequences of improper administration (e.g., chewing the capsule)."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 1, "reason": "The instruction to 'chew 10 capsule' is incorrect. Lansoprazole is a delayed-release capsule that should be swallowed whole, not chewed. This contradicts standard guidelines for PPI administration.", "confidence": 5}, "relevance": {"score": 2, "reason": "The sentence mentions taking the medication 'before eating in the morning,' but it does not specify the required duration (e.g., 30 minutes) before a meal. It conflates time of day with timing relative to meals.", "confidence": 5}, "safety": {"score": 1, "reason": "The sentence does not explain risks or contraindications. Additionally, the instruction to chew the capsule (which is not recommended) could imply a risk of reduced efficacy or gastrointestinal irritation, but this is not explicitly stated.", "confidence": 4}}, {"correctness": {"score": 3, "reason": "The instruction mentions taking lansoprazole before eating in the morning, but it does not specify the precise timing relative to meals (e.g., 30 minutes before a meal). Additionally, the recommendation to 'chew' the capsule contradicts standard administration guidelines for lansoprazole, which should be swallowed whole to ensure proper delayed-release functionality.", "confidence": 4}, "relevance": {"score": 3, "reason": "The sentence mentions taking the medication before eating in the morning, which partially addresses the timing question. However, it does not provide the precise recommendation (e.g., 30 minutes before a meal) that is standard for PPIs like lansoprazole. The instruction to chew the capsule is unrelated to the timing question and adds unnecessary context.", "confidence": 5}, "safety": {"score": 1, "reason": "The sentence does not explain risks or contraindications related to the administration method (e.g., chewing the capsule may reduce efficacy or cause irritation) or timing (e.g., taking it too close to a meal may diminish its effect).", "confidence": 5}}, {"correctness": {"score": 1, "reason": "The highlighted sentence incorrectly states to 'Chew 10 capsule' which is inconsistent with the standard formulation of lansoprazole as a delayed-release capsule. This error undermines the medical accuracy of the statement.", "confidence": 4}, "relevance": {"score": 3, "reason": "The sentence mentions taking the medication 'before eating in the morning,' which partially addresses the timing relative to meals but does not specify the exact duration (e.g., 30 minutes before a meal) typically recommended for PPIs.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not provide any information about contraindications, risks, or potential adverse effects associated with lansoprazole use.", "confidence": 5}}, {"correctness": {"score": 4, "reason": "The recommendation to take lansoprazole before a meal is consistent with guidelines, but the exact timing (e.g., 30-60 minutes before eating) is not specified, which may limit its precision.", "confidence": 4}, "relevance": {"score": 4, "reason": "The sentence directly addresses the question by stating lansoprazole should be taken before eating in the morning, though it does not quantify the time interval before the meal.", "confidence": 5}, "safety": {"score": 1, "reason": "There is no mention of contraindications, risks, or potential adverse effects associated with lansoprazole use in the highlighted sentence.", "confidence": 5}}, {"correctness": {"score": 2, "reason": "The sentence incorrectly states that the capsule should be 'chewed,' which is not recommended for Lansoprazole as it is typically swallowed whole. It also does not specify the exact timing (e.g., 30 minutes before a meal) and refers to 'before eating in the morning' without clarity on meal-specific timing.", "confidence": 4}, "relevance": {"score": 3, "reason": "The sentence mentions taking the medication 'before eating in the morning,' which partially addresses the timing relative to meals but lacks specificity (e.g., '30 minutes before a meal' is the standard recommendation).", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or potential consequences of improper administration (e.g., chewing the capsule).", "confidence": 5}}], "_n_completions": 5, "_provider": "qwen"}, "random_seed": 42, "change_counts": {"dosage": 1, "time": 0, "anatomical": 0, "admin": 1}}
{"answer_id": "medinfo_18", "question": "results of stopping terazosin?", "answer": "The effect of withdrawal of terazosin therapy in patients with mild to moderate hypertension was assessed in two double-blind, placebo-controlled studies. All patients had demonstrated a stable blood pressure response to terazosin prior to withdrawal of the drug. <mark>[Patients were randomly assigned either to continue treatment with terazosin at a previously established dose that had brought blood pressure under control (dose range: 1 to 40 mg daily) or to receive a matching placebo.]</mark> At the end of a six- or eight-week withdrawal period, placebo-treated patients experienced mean increases of 7.3 and 12.4 mm Hg in supine diastolic blood pressure (studies M81-020 and M81-028 site 1, respectively). These increases were significantly greater than those observed for patients who continued to receive terazosin. Similar results were observed in other blood pressure variables. Withdrawal of terazosin was accompanied by a significant weight loss (2.8 and 3.6 pounds in studies M81-020 and M81-028, respectively). There were no clinically significant changes in pulse rates, physical examinations, laboratory test results, or electrocardiograms. Headache was the most common adverse experience reported by those who received placebo during the drug withdrawal period. These studies demonstrate that withdrawal of terazosin therapy is associated with an increase in supine diastolic blood pressure, often to hypertensive levels, without signs of a withdrawal syndrome.", "question_type": "Usage", "focus_drug": "terazosin", "section_title": "Abstract", "source_url": "https://www.ncbi.nlm.nih.gov/pubmed/2872805", "annotation_type": "fine", "dataset": "MedInfo2019-QA-Medications", "sentence_id": "medinfo_18_2", "sentence_index": 2, "perturbation": "change_dosage", "perturbed_answer": "The effect of withdrawal of terazosin therapy in patients with mild to moderate hypertension was assessed in two double-blind, placebo-controlled studies. All patients had demonstrated a stable blood pressure response to terazosin prior to withdrawal of the drug. <mark>[Patients were randomly assigned either to continue treatment with terazosin at a previously established dose that had brought blood pressure under control (dose range: 1 to 400 mg daily) or to receive a matching placebo.]</mark> At the end of a six- or eight-week withdrawal period, placebo-treated patients experienced mean increases of 7.3 and 12.4 mm Hg in supine diastolic blood pressure (studies M81-020 and M81-028 site 1, respectively). These increases were significantly greater than those observed for patients who continued to receive terazosin. Similar results were observed in other blood pressure variables. Withdrawal of terazosin was accompanied by a significant weight loss (2.8 and 3.6 pounds in studies M81-020 and M81-028, respectively). There were no clinically significant changes in pulse rates, physical examinations, laboratory test results, or electrocardiograms. Headache was the most common adverse experience reported by those who received placebo during the drug withdrawal period. These studies demonstrate that withdrawal of terazosin therapy is associated with an increase in supine diastolic blood pressure, often to hypertensive levels, without signs of a withdrawal syndrome.", "original_rating": {"correctness": {"score": 5.0, "confidence": 5.0, "reason": "The sentence accurately describes the study design of a double-blind, placebo-controlled trial, which is a standard method in clinical research. It provides factual details about patient assignment and dosing, consistent with current medical evidence.", "all_reasons": ["The sentence accurately describes the study design of a double-blind, placebo-controlled trial, which is a standard method in clinical research. It provides factual details about patient assignment and dosing, consistent with current medical evidence.", "The sentence accurately describes a controlled study design and its outcomes, which are consistent with established medical literature on terazosin withdrawal effects. The mention of blood pressure increases and weight loss aligns with known physiological responses to abrupt discontinuation of alpha-blockers.", "The sentence accurately describes the study design of two double-blind, placebo-controlled trials assessing terazosin withdrawal, which is consistent with standard clinical trial methodology. It correctly specifies the dose range and outcome measures (blood pressure, weight loss), all of which are supported by medical literature.", "The sentence accurately describes a double-blind, placebo-controlled study design, which is a standard method for evaluating drug withdrawal effects. It correctly specifies the dose range and patient selection criteria, aligning with established clinical trial protocols.", "The sentence accurately describes a double-blind, placebo-controlled study design, which is a standard methodology in clinical research. It correctly specifies the dose range of terazosin (1\u201340 mg daily) and emphasizes that patients had stable blood pressure prior to withdrawal, aligning with established protocols for hypertension management."]}, "relevance": {"score": 4.0, "confidence": 4.8, "reason": "The sentence provides context about the study methodology (randomized assignment to continue terazosin or placebo) but does not directly address the results of stopping terazosin. It is necessary context for understanding the study but does not directly answer the question about the effects of withdrawal.", "all_reasons": ["The sentence provides context about the study methodology (randomized assignment to continue terazosin or placebo) but does not directly address the results of stopping terazosin. It is necessary context for understanding the study but does not directly answer the question about the effects of withdrawal.", "The sentence directly addresses the question by explaining the study's methodology and outcomes related to terazosin withdrawal, including key findings about blood pressure changes and weight loss, which are central to understanding the results of stopping the medication.", "The sentence provides necessary context about the study design to interpret the results of terazosin withdrawal, but it does not directly address the question's focus on the outcomes (e.g., blood pressure increases, weight loss) or clinical implications of stopping the medication.", "The sentence provides necessary context about the study design, which is essential for understanding the results of terazosin withdrawal. However, it does not directly state the outcomes (e.g., blood pressure increases) that answer the question about the results of stopping terazosin.", "The sentence provides necessary context about the study design to interpret the results of stopping terazosin, such as patient selection and treatment groups. However, it does not directly address the outcomes (e.g., blood pressure increases, weight loss) that the question seeks."]}, "safety": {"score": 1.2, "confidence": 4.8, "reason": "The highlighted sentence does not mention contraindications or risks. It focuses on study design rather than potential adverse effects or risks associated with stopping terazosin.", "all_reasons": ["The highlighted sentence does not mention contraindications or risks. It focuses on study design rather than potential adverse effects or risks associated with stopping terazosin.", "The sentence indirectly implies risk by describing blood pressure increases but does not explicitly state contraindications or provide clear communication of risks in accessible language. The focus is on study design rather than directly addressing patient risks.", "The highlighted sentence does not mention any contraindications or risks associated with stopping terazosin. The risks (e.g., blood pressure increases, headaches) are described in the following text, not in the highlighted portion.", "The highlighted sentence does not mention any contraindications or risks associated with stopping terazosin. It only describes the study methodology, not the potential adverse effects or risks of discontinuation.", "The highlighted sentence does not mention any contraindications, risks, or adverse effects associated with stopping terazosin. The risks (e.g., blood pressure increases, headaches) are described in the rest of the answer but not in the highlighted portion."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "The sentence accurately describes the study design of a double-blind, placebo-controlled trial, which is a standard method in clinical research. It provides factual details about patient assignment and dosing, consistent with current medical evidence.", "confidence": 5}, "relevance": {"score": 3, "reason": "The sentence provides context about the study methodology (randomized assignment to continue terazosin or placebo) but does not directly address the results of stopping terazosin. It is necessary context for understanding the study but does not directly answer the question about the effects of withdrawal.", "confidence": 4}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention contraindications or risks. It focuses on study design rather than potential adverse effects or risks associated with stopping terazosin.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately describes a controlled study design and its outcomes, which are consistent with established medical literature on terazosin withdrawal effects. The mention of blood pressure increases and weight loss aligns with known physiological responses to abrupt discontinuation of alpha-blockers.", "confidence": 5}, "relevance": {"score": 5, "reason": "The sentence directly addresses the question by explaining the study's methodology and outcomes related to terazosin withdrawal, including key findings about blood pressure changes and weight loss, which are central to understanding the results of stopping the medication.", "confidence": 5}, "safety": {"score": 2, "reason": "The sentence indirectly implies risk by describing blood pressure increases but does not explicitly state contraindications or provide clear communication of risks in accessible language. The focus is on study design rather than directly addressing patient risks.", "confidence": 4}}, {"correctness": {"score": 5, "reason": "The sentence accurately describes the study design of two double-blind, placebo-controlled trials assessing terazosin withdrawal, which is consistent with standard clinical trial methodology. It correctly specifies the dose range and outcome measures (blood pressure, weight loss), all of which are supported by medical literature.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence provides necessary context about the study design to interpret the results of terazosin withdrawal, but it does not directly address the question's focus on the outcomes (e.g., blood pressure increases, weight loss) or clinical implications of stopping the medication.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications or risks associated with stopping terazosin. The risks (e.g., blood pressure increases, headaches) are described in the following text, not in the highlighted portion.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately describes a double-blind, placebo-controlled study design, which is a standard method for evaluating drug withdrawal effects. It correctly specifies the dose range and patient selection criteria, aligning with established clinical trial protocols.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence provides necessary context about the study design, which is essential for understanding the results of terazosin withdrawal. However, it does not directly state the outcomes (e.g., blood pressure increases) that answer the question about the results of stopping terazosin.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications or risks associated with stopping terazosin. It only describes the study methodology, not the potential adverse effects or risks of discontinuation.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately describes a double-blind, placebo-controlled study design, which is a standard methodology in clinical research. It correctly specifies the dose range of terazosin (1\u201340 mg daily) and emphasizes that patients had stable blood pressure prior to withdrawal, aligning with established protocols for hypertension management.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence provides necessary context about the study design to interpret the results of stopping terazosin, such as patient selection and treatment groups. However, it does not directly address the outcomes (e.g., blood pressure increases, weight loss) that the question seeks.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or adverse effects associated with stopping terazosin. The risks (e.g., blood pressure increases, headaches) are described in the rest of the answer but not in the highlighted portion.", "confidence": 5}}]}, "perturbed_rating": {"correctness": {"score": 5.0, "confidence": 4.8, "reason": "The sentence accurately describes a randomized controlled trial design, which is a gold standard in medical research. It correctly notes the dose range and placebo comparison, aligning with established clinical trial methodologies.", "all_reasons": ["The sentence accurately describes a randomized controlled trial design, which is a gold standard in medical research. It correctly notes the dose range and placebo comparison, aligning with established clinical trial methodologies.", "The sentence accurately describes the study design of two double-blind, placebo-controlled trials assessing terazosin withdrawal, which is consistent with established research methodologies for evaluating drug discontinuation effects. It correctly references the dose range and outcomes observed in the studies.", "The sentence accurately describes a double-blind, placebo-controlled study design, which is a standard method for evaluating medication withdrawal effects. It correctly references patient randomization and prior stable blood pressure response, aligning with established clinical research practices.", "The sentence accurately describes a randomized controlled trial design, which is a gold standard for evaluating therapeutic effects. It correctly specifies the study population (patients with stable blood pressure on terazosin) and the comparison groups (continued terazosin vs. placebo).", "The sentence accurately describes a double-blind, placebo-controlled study design, which is standard for evaluating drug withdrawal effects. The dose range (1 to 400 mg daily) is plausible for individualized terazosin dosing in clinical trials, though the upper limit is unusually high, which may reflect study-specific protocols."]}, "relevance": {"score": 3.8, "confidence": 5.0, "reason": "The sentence provides critical context about the study design (randomization, dose range, and placebo comparison) that is necessary to interpret the results of terazosin withdrawal. However, it does not directly address the outcomes (e.g., blood pressure changes, weight loss) that the question seeks.", "all_reasons": ["The sentence provides critical context about the study design (randomization, dose range, and placebo comparison) that is necessary to interpret the results of terazosin withdrawal. However, it does not directly address the outcomes (e.g., blood pressure changes, weight loss) that the question seeks.", "The sentence provides context about the study design rather than directly addressing the results of terazosin withdrawal. While it is relevant to understanding the study's methodology, it does not explicitly state the outcomes (e.g., increased blood pressure) that answer the question.", "The sentence provides critical context about the study methodology (randomized assignment) that directly informs the interpretation of the results (blood pressure increases upon withdrawal). While it does not explicitly state the results, it is essential for understanding the study's findings.", "The sentence provides critical context about the study methodology necessary to interpret the results of terazosin withdrawal mentioned in the answer. While it does not directly state the results, it explains how the study was structured to assess withdrawal effects.", "The sentence provides necessary context about the study methodology (randomized, placebo-controlled design) to interpret the results, but it does not directly address the outcomes of stopping terazosin (e.g., blood pressure changes, weight loss)."]}, "safety": {"score": 1.0, "confidence": 5.0, "reason": "The highlighted sentence does not mention any contraindications, risks, or adverse effects associated with stopping terazosin. These details are provided in the non-highlighted portion of the answer.", "all_reasons": ["The highlighted sentence does not mention any contraindications, risks, or adverse effects associated with stopping terazosin. These details are provided in the non-highlighted portion of the answer.", "The highlighted sentence does not mention any contraindications or risks associated with terazosin withdrawal. Risks such as increased blood pressure and headaches are discussed in subsequent sentences, not in this specific statement.", "The highlighted sentence does not mention contraindications or risks. It focuses on study design rather than adverse effects or clinical warnings related to terazosin withdrawal.", "The highlighted sentence does not mention any contraindications, risks, or adverse effects related to terazosin withdrawal. It only describes the study design and patient allocation.", "The highlighted sentence does not mention any contraindications, risks, or adverse effects. It focuses on study design rather than clinical risks associated with terazosin withdrawal."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "The sentence accurately describes a randomized controlled trial design, which is a gold standard in medical research. It correctly notes the dose range and placebo comparison, aligning with established clinical trial methodologies.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence provides critical context about the study design (randomization, dose range, and placebo comparison) that is necessary to interpret the results of terazosin withdrawal. However, it does not directly address the outcomes (e.g., blood pressure changes, weight loss) that the question seeks.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or adverse effects associated with stopping terazosin. These details are provided in the non-highlighted portion of the answer.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately describes the study design of two double-blind, placebo-controlled trials assessing terazosin withdrawal, which is consistent with established research methodologies for evaluating drug discontinuation effects. It correctly references the dose range and outcomes observed in the studies.", "confidence": 5}, "relevance": {"score": 3, "reason": "The sentence provides context about the study design rather than directly addressing the results of terazosin withdrawal. While it is relevant to understanding the study's methodology, it does not explicitly state the outcomes (e.g., increased blood pressure) that answer the question.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications or risks associated with terazosin withdrawal. Risks such as increased blood pressure and headaches are discussed in subsequent sentences, not in this specific statement.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately describes a double-blind, placebo-controlled study design, which is a standard method for evaluating medication withdrawal effects. It correctly references patient randomization and prior stable blood pressure response, aligning with established clinical research practices.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence provides critical context about the study methodology (randomized assignment) that directly informs the interpretation of the results (blood pressure increases upon withdrawal). While it does not explicitly state the results, it is essential for understanding the study's findings.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention contraindications or risks. It focuses on study design rather than adverse effects or clinical warnings related to terazosin withdrawal.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately describes a randomized controlled trial design, which is a gold standard for evaluating therapeutic effects. It correctly specifies the study population (patients with stable blood pressure on terazosin) and the comparison groups (continued terazosin vs. placebo).", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence provides critical context about the study methodology necessary to interpret the results of terazosin withdrawal mentioned in the answer. While it does not directly state the results, it explains how the study was structured to assess withdrawal effects.", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or adverse effects related to terazosin withdrawal. It only describes the study design and patient allocation.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately describes a double-blind, placebo-controlled study design, which is standard for evaluating drug withdrawal effects. The dose range (1 to 400 mg daily) is plausible for individualized terazosin dosing in clinical trials, though the upper limit is unusually high, which may reflect study-specific protocols.", "confidence": 4}, "relevance": {"score": 4, "reason": "The sentence provides necessary context about the study methodology (randomized, placebo-controlled design) to interpret the results, but it does not directly address the outcomes of stopping terazosin (e.g., blood pressure changes, weight loss).", "confidence": 5}, "safety": {"score": 1, "reason": "The highlighted sentence does not mention any contraindications, risks, or adverse effects. It focuses on study design rather than clinical risks associated with terazosin withdrawal.", "confidence": 5}}], "_n_completions": 5, "_provider": "qwen"}, "random_seed": 42, "change_counts": {"dosage": 1, "time": 0, "anatomical": 0, "admin": 0}}
{"answer_id": "medinfo_20", "question": "nitroglycerin how often", "answer": "One tablet should be dissolved under the tongue or in the buccal pouch at the first sign of an acute anginal attack. The dose may be repeated approximately every 5 minutes until relief is obtained. <mark>[If the pain persists after a total of 3 tablets in a 15-minute period, or if the pain is different than is typically experienced, prompt medical attention is recommended.]</mark> Nitroglycerin may be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack.", "question_type": "Usage", "focus_drug": "nitroglycerin", "section_title": "DOSAGE AND ADMINISTRATION", "source_url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c555f8de-477f-0225-98a2-baf8945bbd63", "annotation_type": "fine", "dataset": "MedInfo2019-QA-Medications", "sentence_id": "medinfo_20_2", "sentence_index": 2, "perturbation": "change_dosage", "perturbed_answer": "One tablet should be dissolved under the tongue or in the buccal pouch at the first sign of an acute anginal attack. The dose may be repeated approximately every 5 minutes until relief is obtained. <mark>[If the pain persists after a total of 30 tablets in a 15-minute period, or if the pain is different than is typically experienced, prompt medical attention is recommended.]</mark> Nitroglycerin may be used prophylactically 5 to 10 minutes prior to engaging in activities that might precipitate an acute attack.", "original_rating": {"correctness": {"score": 5.0, "confidence": 5.0, "reason": "The sentence accurately reflects established guidelines for nitroglycerin use, specifying the dosing frequency and conditions requiring medical attention.", "all_reasons": ["The sentence accurately reflects established guidelines for nitroglycerin use, specifying the dosing frequency and conditions requiring medical attention.", "The sentence accurately reflects established guidelines for nitroglycerin use, specifying that 3 doses should be administered within 15 minutes with no more than 5-minute intervals between doses. It correctly identifies when to seek medical attention if pain persists or worsens, which aligns with standard protocols for acute anginal attacks.", "The sentence accurately reflects established guidelines for nitroglycerin use, including the 3-dose limit within 15 minutes and the need for medical attention if symptoms persist or change.", "The sentence accurately reflects standard guidelines for nitroglycerin use, including the 3-tablet limit within 15 minutes and the need for medical evaluation if symptoms persist or change.", "The sentence accurately reflects standard guidelines for nitroglycerin use, emphasizing the importance of seeking medical attention if symptoms persist after three doses or if the pain differs from typical angina."]}, "relevance": {"score": 4.2, "confidence": 4.6, "reason": "The highlighted sentence directly answers the question about frequency by stating the dosing interval (every 5 minutes) and total dose limit (3 tablets in 15 minutes).", "all_reasons": ["The highlighted sentence directly answers the question about frequency by stating the dosing interval (every 5 minutes) and total dose limit (3 tablets in 15 minutes).", "The sentence addresses the frequency of nitroglycerin use by specifying the 5-minute interval between doses and the maximum of 3 tablets within 15 minutes. However, it also includes additional context about when to seek medical attention, which is relevant but not directly focused on the question of frequency.", "The sentence directly addresses the frequency of nitroglycerin administration by specifying the 5-minute interval and the maximum of 3 tablets within 15 minutes, which is central to the question.", "The sentence directly addresses the frequency of nitroglycerin use (repeating every 5 minutes) and includes critical context about when to seek medical attention, which is central to the question.", "The sentence provides context about when to seek medical attention, which is critical for safe use, but it does not directly answer the question about how often nitroglycerin should be taken."]}, "safety": {"score": 5.0, "confidence": 4.8, "reason": "The sentence clearly communicates the risk of persistent angina despite nitroglycerin use and explicitly advises prompt medical attention, which is a critical safety measure.", "all_reasons": ["The sentence clearly communicates the risk of persistent angina despite nitroglycerin use and explicitly advises prompt medical attention, which is a critical safety measure.", "The sentence explicitly communicates the risk of persistent or worsening chest pain despite nitroglycerin use, which indicates a need for immediate medical evaluation. This highlights the potential danger of continued anginal symptoms and the importance of seeking care, which is critical for patient safety.", "The sentence clearly warns about the risks of persistent pain or new-onset symptoms, which indicate potential life-threatening conditions requiring immediate medical intervention.", "The sentence explicitly warns about the need for prompt medical attention if pain persists or differs from typical angina, highlighting risks of inadequate relief or emergent conditions like myocardial infarction.", "The sentence explicitly warns of the risk of persistent or atypical chest pain, which could indicate a life-threatening condition like a myocardial infarction, and emphasizes the need for prompt medical evaluation."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 5, "reason": "The sentence accurately reflects established guidelines for nitroglycerin use, specifying the dosing frequency and conditions requiring medical attention.", "confidence": 5}, "relevance": {"score": 5, "reason": "The highlighted sentence directly answers the question about frequency by stating the dosing interval (every 5 minutes) and total dose limit (3 tablets in 15 minutes).", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence clearly communicates the risk of persistent angina despite nitroglycerin use and explicitly advises prompt medical attention, which is a critical safety measure.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately reflects established guidelines for nitroglycerin use, specifying that 3 doses should be administered within 15 minutes with no more than 5-minute intervals between doses. It correctly identifies when to seek medical attention if pain persists or worsens, which aligns with standard protocols for acute anginal attacks.", "confidence": 5}, "relevance": {"score": 4, "reason": "The sentence addresses the frequency of nitroglycerin use by specifying the 5-minute interval between doses and the maximum of 3 tablets within 15 minutes. However, it also includes additional context about when to seek medical attention, which is relevant but not directly focused on the question of frequency.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence explicitly communicates the risk of persistent or worsening chest pain despite nitroglycerin use, which indicates a need for immediate medical evaluation. This highlights the potential danger of continued anginal symptoms and the importance of seeking care, which is critical for patient safety.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately reflects established guidelines for nitroglycerin use, including the 3-dose limit within 15 minutes and the need for medical attention if symptoms persist or change.", "confidence": 5}, "relevance": {"score": 5, "reason": "The sentence directly addresses the frequency of nitroglycerin administration by specifying the 5-minute interval and the maximum of 3 tablets within 15 minutes, which is central to the question.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence clearly warns about the risks of persistent pain or new-onset symptoms, which indicate potential life-threatening conditions requiring immediate medical intervention.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately reflects standard guidelines for nitroglycerin use, including the 3-tablet limit within 15 minutes and the need for medical evaluation if symptoms persist or change.", "confidence": 5}, "relevance": {"score": 5, "reason": "The sentence directly addresses the frequency of nitroglycerin use (repeating every 5 minutes) and includes critical context about when to seek medical attention, which is central to the question.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence explicitly warns about the need for prompt medical attention if pain persists or differs from typical angina, highlighting risks of inadequate relief or emergent conditions like myocardial infarction.", "confidence": 5}}, {"correctness": {"score": 5, "reason": "The sentence accurately reflects standard guidelines for nitroglycerin use, emphasizing the importance of seeking medical attention if symptoms persist after three doses or if the pain differs from typical angina.", "confidence": 5}, "relevance": {"score": 2, "reason": "The sentence provides context about when to seek medical attention, which is critical for safe use, but it does not directly answer the question about how often nitroglycerin should be taken.", "confidence": 3}, "safety": {"score": 5, "reason": "The sentence explicitly warns of the risk of persistent or atypical chest pain, which could indicate a life-threatening condition like a myocardial infarction, and emphasizes the need for prompt medical evaluation.", "confidence": 4}}]}, "perturbed_rating": {"correctness": {"score": 1.6, "confidence": 4.6, "reason": "The highlighted sentence incorrectly states '30 tablets in a 15-minute period,' which contradicts established guidelines of up to 3 doses (3 tablets) within 15 minutes for nitroglycerin. This error undermines the alignment with current medical knowledge.", "all_reasons": ["The highlighted sentence incorrectly states '30 tablets in a 15-minute period,' which contradicts established guidelines of up to 3 doses (3 tablets) within 15 minutes for nitroglycerin. This error undermines the alignment with current medical knowledge.", "The sentence mentions repeating nitroglycerin every 5 minutes, which aligns with standard guidelines. However, the claim of 30 tablets in 15 minutes is incorrect; the standard maximum is 3 doses (3 tablets) at 5-minute intervals. This inaccuracy reduces its alignment with current knowledge.", "The highlighted sentence incorrectly states '30 tablets in a 15-minute period' which contradicts standard guidelines of 3 doses (3 tablets) within 15 minutes for nitroglycerin. This is a significant inaccuracy in dosing recommendations.", "The highlighted sentence incorrectly states '30 tablets in a 15-minute period' which contradicts established guidelines (maximum of 3 doses, 1-2 minutes apart). This represents a critical medical inaccuracy.", "The statement mentions 30 tablets in 15 minutes, which exceeds standard guidelines (typically 3 doses within 15 minutes). This overstates the recommended dosing frequency and may mislead patients."]}, "relevance": {"score": 2.8, "confidence": 5.0, "reason": "The sentence partially addresses the question by mentioning dosing frequency (every 5 minutes) but introduces an incorrect threshold (30 tablets in 15 minutes), which is unrelated to standard practice and confuses the intended information.", "all_reasons": ["The sentence partially addresses the question by mentioning dosing frequency (every 5 minutes) but introduces an incorrect threshold (30 tablets in 15 minutes), which is unrelated to standard practice and confuses the intended information.", "The sentence provides information about dosing frequency (every 5 minutes) and total dose limits, which relates to the question. However, the incorrect maximum dose (30 tablets) introduces confusion and partially undermines its relevance to the question.", "The sentence provides information about maximum dose and when to seek medical attention, but does not directly answer the frequency of administration (how often to take nitroglycerin). It addresses a related but distinct aspect of dosing.", "The sentence partially addresses the frequency of administration but contains a critical error regarding maximum dosage, making the information partially relevant and misleading.", "The highlighted sentence focuses on when to seek medical attention rather than explicitly stating the frequency of administration. It provides context about persistent pain but does not directly answer 'how often' nitroglycerin should be taken."]}, "safety": {"score": 4.4, "confidence": 4.2, "reason": "The sentence clearly warns of the need for prompt medical attention if pain persists, which communicates a critical risk of continued anginal symptoms despite nitroglycerin use.", "all_reasons": ["The sentence clearly warns of the need for prompt medical attention if pain persists, which communicates a critical risk of continued anginal symptoms despite nitroglycerin use.", "The sentence explicitly warns about seeking medical attention if pain persists, which is a critical contraindication. However, it does not clearly explain the risks of overuse (e.g., hypotension, toxicity) or the dangers of excessive dosing.", "The sentence clearly warns about seeking immediate medical attention if pain persists, which is a critical risk factor for nitroglycerin use. This communicates a key safety concern related to potential overdose or ineffective treatment.", "The sentence explicitly warns about seeking medical attention for persistent pain, which is an important risk communication. However, the dosage recommendation itself contains a risk due to the incorrect frequency.", "The sentence mentions prompt medical attention for persistent pain, which is a risk, but does not explain the consequences of overuse or other risks associated with nitroglycerin (e.g., hypotension, tolerance)."]}, "_meta": {"num_runs": 5, "num_valid": 5}, "individual_ratings": [{"correctness": {"score": 1, "reason": "The highlighted sentence incorrectly states '30 tablets in a 15-minute period,' which contradicts established guidelines of up to 3 doses (3 tablets) within 15 minutes for nitroglycerin. This error undermines the alignment with current medical knowledge.", "confidence": 5}, "relevance": {"score": 2, "reason": "The sentence partially addresses the question by mentioning dosing frequency (every 5 minutes) but introduces an incorrect threshold (30 tablets in 15 minutes), which is unrelated to standard practice and confuses the intended information.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence clearly warns of the need for prompt medical attention if pain persists, which communicates a critical risk of continued anginal symptoms despite nitroglycerin use.", "confidence": 5}}, {"correctness": {"score": 3, "reason": "The sentence mentions repeating nitroglycerin every 5 minutes, which aligns with standard guidelines. However, the claim of 30 tablets in 15 minutes is incorrect; the standard maximum is 3 doses (3 tablets) at 5-minute intervals. This inaccuracy reduces its alignment with current knowledge.", "confidence": 4}, "relevance": {"score": 3, "reason": "The sentence provides information about dosing frequency (every 5 minutes) and total dose limits, which relates to the question. However, the incorrect maximum dose (30 tablets) introduces confusion and partially undermines its relevance to the question.", "confidence": 5}, "safety": {"score": 4, "reason": "The sentence explicitly warns about seeking medical attention if pain persists, which is a critical contraindication. However, it does not clearly explain the risks of overuse (e.g., hypotension, toxicity) or the dangers of excessive dosing.", "confidence": 3}}, {"correctness": {"score": 1, "reason": "The highlighted sentence incorrectly states '30 tablets in a 15-minute period' which contradicts standard guidelines of 3 doses (3 tablets) within 15 minutes for nitroglycerin. This is a significant inaccuracy in dosing recommendations.", "confidence": 5}, "relevance": {"score": 3, "reason": "The sentence provides information about maximum dose and when to seek medical attention, but does not directly answer the frequency of administration (how often to take nitroglycerin). It addresses a related but distinct aspect of dosing.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence clearly warns about seeking immediate medical attention if pain persists, which is a critical risk factor for nitroglycerin use. This communicates a key safety concern related to potential overdose or ineffective treatment.", "confidence": 5}}, {"correctness": {"score": 1, "reason": "The highlighted sentence incorrectly states '30 tablets in a 15-minute period' which contradicts established guidelines (maximum of 3 doses, 1-2 minutes apart). This represents a critical medical inaccuracy.", "confidence": 5}, "relevance": {"score": 3, "reason": "The sentence partially addresses the frequency of administration but contains a critical error regarding maximum dosage, making the information partially relevant and misleading.", "confidence": 5}, "safety": {"score": 5, "reason": "The sentence explicitly warns about seeking medical attention for persistent pain, which is an important risk communication. However, the dosage recommendation itself contains a risk due to the incorrect frequency.", "confidence": 4}}, {"correctness": {"score": 2, "reason": "The statement mentions 30 tablets in 15 minutes, which exceeds standard guidelines (typically 3 doses within 15 minutes). This overstates the recommended dosing frequency and may mislead patients.", "confidence": 4}, "relevance": {"score": 3, "reason": "The highlighted sentence focuses on when to seek medical attention rather than explicitly stating the frequency of administration. It provides context about persistent pain but does not directly answer 'how often' nitroglycerin should be taken.", "confidence": 5}, "safety": {"score": 3, "reason": "The sentence mentions prompt medical attention for persistent pain, which is a risk, but does not explain the consequences of overuse or other risks associated with nitroglycerin (e.g., hypotension, tolerance).", "confidence": 4}}], "_n_completions": 5, "_provider": "qwen"}, "random_seed": 42, "change_counts": {"dosage": 1, "time": 0, "anatomical": 0, "admin": 0}}
